INDEMNIFICATION AGREEMENTIndemnification Agreement • August 13th, 2013 • Innovus Pharmaceuticals, Inc. • Blank checks • Nevada
Contract Type FiledAugust 13th, 2013 Company Industry JurisdictionTHIS INDEMNIFICATION AGREEMENT is made and entered into as of June __, 2013, by and between Innovus Pharmaceuticals, Inc., a Nevada corporation (the "Company") and _____________ ("Indemnitee"), as an "Agent" (as hereinafter defined) of the Company.
INNOVUS PHARMACEUTICALS, INC. MAY 2013 AMENDMENT TO 8% CONVERTIBLE DEBENTURE8% Convertible Debenture Amendment • August 13th, 2013 • Innovus Pharmaceuticals, Inc. • Blank checks
Contract Type FiledAugust 13th, 2013 Company IndustryTHIS AMENDMENT TO 8% CONVERTIBLE DEBENTURE (“Amendment”) is entered into as of May 4, 2013 (the “Effective Date”), by and among Innovus Pharmaceuticals, Inc., a Nevada corporation ("Issuer"), and [ ] ("Debenture Holder").
INNOVUS PHARMACEUTICALS, INC. MAY 2013 AMENDMENT TO AMENDED AND RESTATED 8% CONVERTIBLE DEBENTURE8% Convertible Debenture • August 13th, 2013 • Innovus Pharmaceuticals, Inc. • Blank checks
Contract Type FiledAugust 13th, 2013 Company IndustryTHIS MAY 2013 AMENDMENT TO AMENDED AND RESTATED 8% CONVERTIBLE DEBENTURE (“Amendment”) is entered into as of May 6, 2013 (the “Effective Date”), by and among Innovus Pharmaceuticals, Inc., a Nevada corporation ("Issuer"), and Bassam Damaj ("Debenture Holder").
INNOVUS PHARMACEUTICALS, INC. EQUITY UNIT AGREEMENTEquity Unit Agreement • August 13th, 2013 • Innovus Pharmaceuticals, Inc. • Blank checks • California
Contract Type FiledAugust 13th, 2013 Company Industry JurisdictionTHIS EQUITY UNIT AGREEMENT (this “Agreement”) is made and entered into as of May 15, 2013 (the “Effective Date”), by and between INNOVUS PHARMACEUTICALS, INC., a Nevada corporation (“Issuer”), and _____________, an individual (“Investor”).
Subscription AgreementSubscription Agreement • August 13th, 2013 • Innovus Pharmaceuticals, Inc. • Blank checks • California
Contract Type FiledAugust 13th, 2013 Company Industry JurisdictionThis Subscription Agreement (this “Subscription Agreement”) is entered into as of June 12, 2013, by and among Innovus Pharmaceuticals, Inc., a Nevada corporation (the “Company”), and the investors on the signature page hereof (each, an “Investor,” and together, the “Investors”).
CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • August 13th, 2013 • Innovus Pharmaceuticals, Inc. • Blank checks • California
Contract Type FiledAugust 13th, 2013 Company Industry JurisdictionThis Change in Control and Severance Agreement (this “Agreement”) is entered into by and between Morgan R. Brown (“Employee,” “you,” or “your”) and Innovus Pharmaceuticals, Inc., a Nevada corporation (the “Company”). This Agreement has an effective date of August 9, 2013 (the “Effective Date”).